Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biovail Says Tiazac Andrx Settlement “Satisfies” FTC; Patent Remains Listed

Feb 25 2002

• By The Pink Sheet

Related Content

AHP K-Dur Settlement With FTC Applies To Brand And Generic Divisions

Feb 25 2002

“Orange Book” Listings Are Not Immune From Antitrust Scrutiny, FTC Says

Jan 14 2002

ANDA Amendments Should Trigger New Paragraph IV Certifications – Biovail

Jan 14 2002

Andrx Generic Prilosec Clears FDA; Approval Could Expedite Patent Litigation

Nov 19 2001

FTC K-Dur Suit Would Allow Andrx Generic Launch; FDA Could Act First

Apr 09 2001

Generic Stay May Be Shortened Based Only On Behavior In Trial – Appeals Court

Jan 28 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window